文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

我们准备好申请报销了吗？关于健康技术评估的真实世界证据发展综述：第20部分。

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20.

作者信息

Arora Paul, Ramagopalan Sreeram V

机构信息

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.

Inka Health, 100 King St. W. Suite 1600, Toronto, ON M5X 1G5, Canada.

出版信息

J Comp Eff Res. 2025 Sep;14(9):e250113. doi: 10.57264/cer-2025-0113. Epub 2025 Jul 23.

DOI:10.57264/cer-2025-0113
PMID:40698536
Abstract

In this update, we examine Canada's Drug Agency position statement on artificial intelligence in evidence generation, a systematic review of clinical trial data linkage approaches, and real-world effectiveness evidence from England's respiratory syncytial virus vaccination program.

摘要

在本次更新中，我们审视了加拿大药品管理局关于人工智能在证据生成方面的立场声明、对临床试验数据关联方法的系统评价，以及来自英格兰呼吸道合胞病毒疫苗接种计划的真实世界有效性证据。

相似文献

[1]
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 20.

J Comp Eff Res. 2025-9

[2]
Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study.

Lancet Child Adolesc Health. 2025-7-18

[3]
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.

Vaccine. 2024-3-7

[4]
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes.

Cochrane Database Syst Rev. 2024-5-2

[5]
Environmental sustainability in health technology assessment: an analysis of the activities of Canada's Drug Agency and the England's NICE.

Int J Technol Assess Health Care. 2025-7-21

[6]
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.

J Comp Eff Res. 2025-1

[7]
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19.

J Comp Eff Res. 2025-7

[8]
Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.

Artif Intell Med. 2023-6

[9]
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.

Hum Vaccin Immunother. 2025-12

[10]
Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia.

Vaccine. 2024-12-2

本文引用的文献

[1]
Respiratory syncytial virus: health burden, disease prevention, and treatment-recent progress and lessons learned.

Microlife. 2025-2-10

[2]
Using Generative Artificial Intelligence in Health Economics and Outcomes Research: A Primer on Techniques and Breakthroughs.

Pharmacoecon Open. 2025-4-29

[3]
Linkage of Clinical Trial Data to Routinely Collected Data Sources: A Scoping Review.

JAMA Netw Open. 2025-4-1

[4]
Early impact of RSV vaccination in older adults in England.

Lancet. 2025-4-5

[5]
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.

J Comp Eff Res. 2025-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索